| Smitha Neerukonda, | |
|
1800 15th St Ste 310, Greeley, CO 80631-4562 | |
| (970) 810-0900 | |
| Not Available |
| Full Name | Smitha Neerukonda |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 1800 15th St Ste 310, Greeley, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669835013 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | DR.0068556 (Colorado) | Primary |
| Entity Name | Banner Health Physicians Colorado Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073899134 PECOS PAC ID: 8921273038 Enrollment ID: O20111219000237 |
News Archive
Taiwanese startup Health2Sync announced their strategic partnership with Taiwan's Ministry of Health and Welfare (MOHW) in bringing online diabetes care nation-wide.
The Wall Street Journal: "Cigna Corp. is expanding overseas, leading a push by health insurers to find growth amid uncertainties at home. Next month, the Philadelphia-based firm will launch an insurance policy in Spain that it says is the first of its kind to be sold by U.S. insurers. The new plan is sold directly to local individuals, as opposed to employer-sponsored or supplemental policies offered by Cigna in 26 other countries.
Boehringer Ingelheim and Priaxon entered into a worldwide collaboration to research and develop mdm2/p53 inhibitors for the treatment of cancer. Priaxon is providing its innovative and proprietary small molecule drug discovery expertise which is particularly suited to investigate inhibition of protein-protein interactions. p53 is a human tumor suppressor protein.
A Regenstrief scientist is calling on the Centers for Medicare and Medicaid Services to create access to better care for the 20 million Americans affected by Alzheimer's disease and related dementias - both patients and their caregivers.
Healthy individuals with higher levels of albumin excretion, even levels considered normal, are at increased risk of developing hypertension (high blood pressure), according to a study appearing in the October 2008 issue of the Journal of the American Society Nephrology (JASN).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Smitha Neerukonda, 1800 15th St Ste 310, Greeley, CO 80631-4562 Ph: () - | Smitha Neerukonda, 1800 15th St Ste 310, Greeley, CO 80631-4562 Ph: (970) 810-0900 |
News Archive
Taiwanese startup Health2Sync announced their strategic partnership with Taiwan's Ministry of Health and Welfare (MOHW) in bringing online diabetes care nation-wide.
The Wall Street Journal: "Cigna Corp. is expanding overseas, leading a push by health insurers to find growth amid uncertainties at home. Next month, the Philadelphia-based firm will launch an insurance policy in Spain that it says is the first of its kind to be sold by U.S. insurers. The new plan is sold directly to local individuals, as opposed to employer-sponsored or supplemental policies offered by Cigna in 26 other countries.
Boehringer Ingelheim and Priaxon entered into a worldwide collaboration to research and develop mdm2/p53 inhibitors for the treatment of cancer. Priaxon is providing its innovative and proprietary small molecule drug discovery expertise which is particularly suited to investigate inhibition of protein-protein interactions. p53 is a human tumor suppressor protein.
A Regenstrief scientist is calling on the Centers for Medicare and Medicaid Services to create access to better care for the 20 million Americans affected by Alzheimer's disease and related dementias - both patients and their caregivers.
Healthy individuals with higher levels of albumin excretion, even levels considered normal, are at increased risk of developing hypertension (high blood pressure), according to a study appearing in the October 2008 issue of the Journal of the American Society Nephrology (JASN).
› Verified 7 days ago
Dr. John Paul Berger, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 6767 29th St Fl 2, Greeley, CO 80634 Phone: 970-624-2414 Fax: 970-490-4155 | |
Dr. Sheldon Gregory Stadnyk, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1801 16th St, Greeley, CO 80631 Phone: 970-350-6002 | |
Dr. Veronika Panah, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2010 16th St Ste A, Greeley, CO 80631 Phone: 970-810-4475 | |
Dr. Steven O Kading, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1900 16th St, Greeley, CO 80631 Phone: 970-350-2740 Fax: 970-352-3719 | |
Dr. Brian J Daily, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 6767 29th St, Greeley, CO 80634 Phone: 970-652-2000 | |
Dr. Bryan Paul Mcvay, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 6767 29th St Fl 2, Greeley, CO 80634 Phone: 970-224-9102 | |
Dr. Jimmy Giang, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 8225 W 20th St, Greeley, CO 80634 Phone: 970-378-1414 |